Sign in

CIK 0001601830

  • Large accelerated filer

RECURSION PHARMACEUTICALS, INC.

Sign in to watch
Ticker
RXRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464099738
Phone
+1 385-269-0203
Business address
41S RIO GRANDE STREET, SALT LAKE CITY, UT, 84101
Former names
Recursion Pharmaceuticals, LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$701,222
in 5 filings, $701K under 10b5-1 plans

Net −$701,222. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-02-15 Secora Michael Chief Financial Officer Shares withheld for taxes −7,172 $12.43 $89K 1,179,179
2024-02-15 Marriott Tina President and COO Shares withheld for taxes −5,379 $12.43 $67K 639,982
2024-02-15 Gibson Christopher Chief Executive Officer Shares withheld for taxes −11,148 $12.43 $139K 1,104,919
2024-02-14 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +37,500 $2.22 $83K 1,211,351
2024-02-14 Secora Michael Chief Financial Officer Sale 10b5-1 −23,933 $10.43 $250K 1,187,418
2024-02-14 Secora Michael Chief Financial Officer Sale 10b5-1 −1,067 $10.98 $12K 1,186,351
2024-02-14 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −37,500 960,135
2024-02-13 Secora Michael Chief Financial Officer Exercise or conversion 10b5-1 +37,500 $2.22 $83K 1,198,851
2024-02-13 Secora Michael Chief Financial Officer Sale 10b5-1 −25,000 $9.86 $247K 1,173,851
2024-02-13 Secora Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) 10b5-1 −37,500 997,635
2024-02-09 Mauro David J Chief Medical Officer Grant or award +6,040 196,753
2024-02-09 Mauro David J Chief Medical Officer Grant or award +49,768 246,521
2024-02-09 Mauro David J Chief Medical Officer Shares withheld for taxes −1,892 $10.09 $19K 244,629
2024-02-09 Mauro David J Chief Medical Officer Grant or award · Stock Option (RIght to Buy) +99,537 99,537
2024-02-09 Secora Michael Chief Financial Officer Grant or award +8,659 989,673
2024-02-09 Secora Michael Chief Financial Officer Grant or award +174,190 1,163,863
2024-02-09 Secora Michael Chief Financial Officer Shares withheld for taxes −2,512 $10.09 $25K 1,161,351
2024-02-09 Secora Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +348,380 348,380
2024-02-09 Marriott Tina President and COO Grant or award +9,655 424,203
2024-02-09 Marriott Tina President and COO Grant or award +223,958 648,161

Page 24 of 41 · 805 trades